We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Recommends Gilead’s Truvada as First HIV Prevention Drug
FDA Panel Recommends Gilead’s Truvada as First HIV Prevention Drug
May 11, 2012
An FDA advisory panel is recommending approval for Gilead’s Truvada as the first treatment to prevent sexually transmitted HIV in uninfected people.